FMP
Daxor Corporation
DXR
NASDAQ
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
9.8 USD
0.25 (2.55%)
About
ceo
Mr. Michael Richard Feldschuh
sector
Healthcare
industry
Medical - Instruments & Supplies
website
https://www.daxor.com
exchange
NASDAQ
Description
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
CIK
0000027367
ISIN
US2394671034
CUSIP
239467103
Address
109 Meco Lane
Phone
12123308500
Country
US
Employee
37
IPO Date
Jul 25, 1983
Summary
CIK
0000027367
Exchange
NASDAQ
Industry
Medical - Instrument...
Sector
Healthcare
CUSIP
239467103
ISIN
US2394671034
Country
US
Price
9.8
Beta
-0.43
Volume Avg.
2.56k
Market Cap
46.4M
Shares
-
52-Week
7.11-13.13
DCF
0.99
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
70
P/B
-
Website
https://www.daxor.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest DXR News
It looks like there's no news available.
